18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization

By sjmartinez • November 22, 2022

Packard RRS, Votaw JR, Cooke CD, Van Train KF, Garcia EV, Maddahi J. 18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization. Eur Heart J Cardiovasc Imaging. 2022 Nov 17;23(12):1636-1644. doi: 10.1093/ehjci/jeab267. PMID: 34928321; PMCID: PMC9671402.

Tags: Cardiology/Epi, diagnostic performance, flurpiridaz, myocardial blood flow, perfusion, PET, Publications, segmental

Evaluating associations of oxylipin metabolites and fatty acids with incident and prevalent type 2 diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

Downie CG, Highland HM, Howard AG, Alotaibi M, Elfassy T, Cordero C, Below JE, Carnethon M, Cheng S, Daviglus M, Garcia-Bedoya O, Kaplan R, Khambaty[...]

Safety and Effectiveness of a Novel Laser-Based Intravascular Lithotripsy System for Coronary Calcium: FRACTURE Study

McEntegart M, Budrys P, Sharma S, Spratt JC, Nef H, Jefferson B, Verouden N, Corrigan FE 3rd, De Silva K, Chatterjee D, Price M, Webb[...]

Pulmonary Index of Microcirculatory Resistance: A Novel Hemodynamic Index for Invasively Assessing the Pulmonary Microvasculature

Parikh RV, Klomhaus A, Chen JY, Assi A, Bassam K, Channick R, Fearon WF, Aboulhosn J, Saggar R. Pulmonary Index of Microcirculatory Resistance: A Novel[...]